We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRTS:NASDAQCarParts.com, Inc. Analysis

Data as of 2026-09-01 - not real-time

$7.48

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $7.48, CarParts.com, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 54.2%. Momentum indicators put RSI at 70.2 (overbought) with MACD reading bullish. Recent trading has carved out support near $5.47 and resistance around $7.82.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 45.1% above where the shares trade now. Revenue is contracting at 10.7% on a -5.4% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 85.2%, a beta of 1.39 and a maximum drawdown of 65.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Updated Aug 6, 2026 0 LONG BEACH, Calif., Aug. 6, 2026 /PRNewswire/ -- CarParts.com, Inc.  NASDAQ: PRTS , a leading...LONG BEACH, Calif., Aug. 6, 2026 /PRNewswire/ -- CarParts.com, Inc. NASDAQ: PRTS , a leading eCommerce provider of...ad-hoc-news1monPRTS stock trades on CarParts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 70.2 signals overbought conditions
  • Trading above the 200-day average of 6.36
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 70.2 signals overbought conditions
  • Trading above the 200-day average of 6.36
  • Analyst targets imply +45.1% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -5.4%
  • Analyst targets imply +45.1% versus the current price
  • Negative return on equity of -46.3%

Key Metrics & Analysis

Financial Health

Revenue Growth-10.70%
Profit Margin-5.35%
P/E Ratio-3.8
ROE-46.31%
ROA-8.00%
Debt/Equity90.05
P/B Ratio1.0
Op. Cash Flow$-3373000
Free Cash Flow$5.0M

Technical Analysis

TrendNeutral
RSI70.2
Support$5.47
Resistance$7.82
MA 20$6.48
MA 50$5.99
MA 200$6.36
MACDBullish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Fair Value$6.20
Target Price$10.85
Upside/Downside45.05%
GradeFair
TypeBlend

Risk Assessment

Beta1.39
Volatility85.24%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.